Dipharma Inc. – FDA Inspection, Jan 11, 2024

Record Details

This FDA Inspection record concerns Dipharma Inc., with an inspection on January 11, 2024, issued by the Detroit District Office, covering human drugs.

Company: Dipharma Inc.
Inspection Date: January 11, 2024
Product Type: Human Drugs
Office: Detroit District Office
People: Jacob G. Lutz (FDA Associated Person)
Joohi Castelvetere
Nicholas J. Presto (Issuing Officer)

View Company Profile

ID · ab788b7f-def3-4200-997b-aa2f6c4efb53

Inspection Facts

Inspection number: 1228260
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dipharma Inc.

FDA Inspection

Dipharma Inc.January 11, 2024

Dipharma Inc. – FDA Inspection, Jan 11, 2024

Record Details

This FDA Inspection record concerns Dipharma Inc., with an inspection on January 11, 2024, issued by the Detroit District Office, covering human drugs.